stockportfolio.pro
STE vs UTHR: Which Stock Is the Better Buy?
STERIS plc and United Therapeutics Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — STE vs UTHR, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| STERIS plc (STE) | United Therapeutics Corporation (UTHR) | |
|---|---|---|
| Market cap | $21.3B | $23.0B |
| Revenue (latest FY) | $5.94B | $3.18B |
| Net income (latest FY) | $782.30M | $1.33B |
| Revenue growth (5y CAGR) | 13.8% | 16.5% |
| Net margin | 13.2% | 41.9% |
| Return on equity | 10.9% | 18.8% |
| P/E ratio | 27.6 | 20.0 |
| Dividend yield | 1.1% | — |
| Profitable years (of last 10) | 10 | 8 |
| Positive free cash flow | Yes | Yes |
See the full STE vs UTHR breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open STE's full financials → Open UTHR's full financials →More comparisons
Frequently asked questions
Which is bigger, STE or UTHR?
United Therapeutics Corporation is larger by market capitalization — $23.0B versus $21.3B.
Which grows faster, STE or UTHR?
Over the last five fiscal years, United Therapeutics Corporation grew revenue faster — 16.5%/yr versus 13.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.